Numares Targets Kidney Transplantation “Blind Spot” With Metabolomics-Based Urine Test

 
• By Marion Webb
  
Germany-based diagnostics company numares Health develops a metabolomics-based urine test to help doctors detect kidney transplantation rejection earlier than currently available biomarkers. (Shutterstock)

More from HIMSS

More from Conferences